** = Publications listed in SCI/SSCI/Pubmed
** Vejzovic, D; Karner, C; Fechter, K; Ritter, G; Holzer, V; Barones, L; Schweintzger, NA; Wagner, K; Lyssy, F; Gauster, M; Szkandera, J; Stanzer, S; Prietl, B; El-Heliebi, A; Lohberger, B; Guillén-Navaro, MJ; Avilés, PM; Brčić, I; Liegl-Atzwanger, B; Rinner, B
Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma.
Cancer Lett. 2025; 218131
Doi: 10.1016/j.canlet.2025.218131
PubMed
FullText
FullText_MUG
** Vejzovic, D; Kubin, A; Fechter, K; Karner, C; Hartmann, J; Ackerbauer, T; Radović, B; Ritter, G; Üçal, M; Ropele, S; Ali, KM; Mischkulnig, M; Leoni, M; Liegl-Atzwanger, B; Wightman, L; Rinner, B
Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing.
Biomed Pharmacother. 2025; 186:118041
Doi: 10.1016/j.biopha.2025.118041
PubMed
FullText
FullText_MUG